These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30476082)

  • 1. Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy.
    Nitta T; Kanoh H; Inamori KI; Suzuki A; Takahashi T; Inokuchi JI
    Glycobiology; 2019 Mar; 29(3):260-268. PubMed ID: 30476082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
    Yao T; Zha D; Gao P; Shui H; Wu X
    J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Nakao K
    Clin Exp Nephrol; 2014 Aug; 18(4):584-92. PubMed ID: 24357461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.
    Omote K; Gohda T; Murakoshi M; Sasaki Y; Kazuno S; Fujimura T; Ishizaka M; Sonoda Y; Tomino Y
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1335-47. PubMed ID: 24647715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
    Awad AS; You H; Gao T; Cooper TK; Nedospasov SA; Vacher J; Wilkinson PF; Farrell FX; Brian Reeves W
    Kidney Int; 2015 Oct; 88(4):722-33. PubMed ID: 26061548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid alleviates inflammation and against diabetes‑induced nephropathy through TLR4‑mediated inflammatory pathway.
    Li J; Li N; Yan S; Liu M; Sun B; Lu Y; Shao Y
    Mol Med Rep; 2018 Nov; 18(5):4675-4681. PubMed ID: 30221655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
    Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
    Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy.
    Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells.
    Legros N; Ptascheck S; Pohlentz G; Karch H; Dobrindt U; Müthing J
    Glycobiology; 2019 Oct; 29(11):789-802. PubMed ID: 31361021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
    Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
    Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
    Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
    Jialal I; Major AM; Devaraj S
    J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between TLR4 genetic polymorphisms and diabetic nephropathy in a Chinese population.
    Peng D; Wang J; Pan J; Zhang R; Tang S; Jiang F; Chen M; Yan J; Sun X; Wang T; Wang S; Bao Y; Jia W
    Biomed Res Int; 2014; 2014():704167. PubMed ID: 24779014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice.
    Cha JJ; Hyun YY; Lee MH; Kim JE; Nam DH; Song HK; Kang YS; Lee JE; Kim HW; Han JY; Cha DR
    Endocrinology; 2013 Jun; 154(6):2144-55. PubMed ID: 23568555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.